Home LiteratureArticle Details
PMID: 6286488 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Intratypic and intertypic specificity of lymphocytes involved in the recognition of herpes simplex virus glycoproteins.

Infection and immunity ·Vol. 37 ·No. 1 ·1982-07-00 ·Pages 116-26

Carter VC, Rice PL, Tevethia SS

Abstract

Cytotoxic T lymphocytes (CTL) were generated in C57BL/6 mice with herpes simplex virus type 1 (HSV-1) (strains KOS, 17, HFEM, and mP) and HSV-2 (strains 186, G, and GP6). Effector lymphocytes were tested for cytotoxicity against syngeneic HSV-1- and HSV-2-infected cells in a 5-h 51Cr release assay. HSV-1 strain HFEM was found to induce CTL efficiently only when 100-fold more virus was used as compared with HSV-1 strains KOS, 17, and mP. All HSV-1 and HSV-2 strains induced cross-reactive populations of CTL. CTL generated by HSV-1 KOS and HSV-2 186 also demonstrated cross-reactivity in an ear-swelling model for delayed-type hypersensitivity. Lymphocytes generated by all HSV-2 strains were highly efficient at lysing HSV-1-infected target cells. However, HSV-2-infected target cells were found to be less susceptible to lysis by either HSV-1 or HSV-2 CTL than were HSV-1-infected target cells. The lowered susceptibility of HSV-2-infected cells was not due to an inefficient infection of BL/6 WT-3 cells as measured by standard growth assays and infectious center assays. Varying the multiplicity of infection or the time of infection did not increase the susceptibility of HSV-2-infected target cells to lysis by CTL. Increasing the effector-to-target-cell ratio resulted in an increased lysis of both HSV-1- and HSV-2-infected target cells by CTL, but the level of HSV-2-infected target cell lysis still did not approach the level of HSV-1-infected target cell lysis. HSV-2-infected cells were as efficient as HSV-1-infected cells in the cold cell competition assay employed in reducing the lysis of 51Cr-labeled, HSV-1-infected target cells. In addition, HSV-2-infected cells were susceptible to lysis by HSV-immune serum and complement.

MeSH Terms
Animals Antibodies, Viral/immunology Cytotoxicity, Immunologic Glycoproteins/immunology Hypersensitivity, Delayed Mice Mice, Inbred C57BL Simplexvirus/classification,growth & development,immunology Species Specificity T-Lymphocytes/immunology Viral Proteins/immunology
Chemicals
Antibodies, Viral Glycoproteins Viral Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Carter V C
Rice P L
Tevethia S S
References (54)
54 references, click to expand
  1. Delayed hypersensitivity to herpes simplex virus in the guinea pig.
    J Immunol. 1966 Jun;96(6):981-7 PMID: 4287991
  2. A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties.
    Am J Epidemiol. 1968 May;87(3):647-55 PMID: 5694774
  3. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.
    J Gen Virol. 1968 May;2(3):357-64 PMID: 4300104
  4. Genetic relatedness of type 1 and type 2 herpes simplex viruses.
    J Virol. 1972 May;9(5):738-45 PMID: 4337161
  5. Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2.
    J Immunol. 1972 Sep;109(3):554-64 PMID: 4341272
  6. Sensitization of guinea pigs to herpes simplex virus.
    J Immunol. 1972 Oct;109(4):801-7 PMID: 4342290
  7. Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map.
    J Gen Virol. 1973 Mar;18(3):329-46 PMID: 4348796
  8. The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.
    J Gen Virol. 1973 May;19(2):217-33 PMID: 4351780
  9. A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.
    Cancer Res. 1973 Jun;33(6):1469-76 PMID: 4352384
  10. Isolation, complementation and preliminary phenotypic characterization of temperature-sensitive mutants of herpes simplex virus type 2.
    Virology. 1974 Feb;57(2):554-65 PMID: 4361460
  11. Herpes simplex virus-specific polypeptides studied by polyacrylamide gel electrophoresis of immune precipitates.
    J Gen Virol. 1974 Feb;22(2):171-85 PMID: 4362401
  12. Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.
    J Virol. 1974 Sep;14(3):640-51 PMID: 4369085
  13. Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells.
    Virology. 1975 Jul;66(1):217-28 PMID: 166500
  14. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    J Immunol. 1976 Jan;116(1):35-40 PMID: 173758
  15. Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.
    J Virol. 1976 Mar;17(3):991-1008 PMID: 176453
  16. Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity.
    Transplant Rev. 1976;29:89-124 PMID: 58463
  17. T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells.
    Nature. 1977 Feb 17;265(5595):630-2 PMID: 193023
  18. Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells.
    Virology. 1977 Apr;77(2):733-49 PMID: 193259
  19. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes.
    J Immunol. 1977 Sep;119(3):939-44 PMID: 70478
  20. Anatomy of herpes simplex virus DNA. IX. Apparent exclusion of some parental DNA arrangements in the generation of intertypic (HSV-1 X HSV-2) recombinants.
    J Virol. 1977 Oct;24(1):231-48 PMID: 198577
  21. Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 or 2.
    Z Immunitatsforsch Immunobiol. 1977 Jul;153(2):162-73 PMID: 198986
  22. Some properties of recombinants between type 1 and type 2 herpes simplex viruses.
    J Gen Virol. 1977 Sep;36(3):471-84 PMID: 199695
  23. Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants.
    J Virol. 1978 May;26(2):389-410 PMID: 207894
  24. Complement-mediated cytolysis of HSV-1 and HSV-2 infected cells: plasma membrane antigens reactive with type-specific and cross-reactive antibody.
    J Gen Virol. 1978 Aug;40(2):443-54 PMID: 211189
  25. Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein.
    J Virol. 1978 Jul;27(1):172-81 PMID: 80458
  26. Crossed immunoelectrophoresis of a herpes simplex virus type 1-specific antigen: immunological and biochemical characterization.
    J Infect Dis. 1978 Nov;138(5):639-43 PMID: 81867
  27. Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene.
    Proc Natl Acad Sci U S A. 1979 Jan;76(1):442-6 PMID: 218202
  28. Specificity of cytotoxicity T cells directed to influenza virus hemagglutinin.
    J Exp Med. 1979 Apr 1;149(4):856-69 PMID: 311817
  29. Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells.
    J Virol. 1979 Feb;29(2):677-97 PMID: 219254
  30. Anatomy of herpes simplex virus DNA. XI. Apparent clustering of functions effecting rapid inhibition of host DNA and protein synthesis.
    J Virol. 1979 Feb;29(2):825-7 PMID: 219262
  31. The structure and isomerization of herpes simplex virus genomes.
    Cell. 1979 Mar;16(3):481-94 PMID: 222462
  32. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). V In vitro demonstration of SV40 TrAg in SV40 infected nonpermissive mouse cells by the lymphocyte mediated cytotoxicity assay.
    Virology. 1979 Aug;97(1):32-41 PMID: 224580
  33. Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.
    J Virol. 1979 Dec;32(3):741-8 PMID: 229263
  34. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein.
    J Virol. 1979 Dec;32(3):779-89 PMID: 229267
  35. Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes.
    Infect Immun. 1980 Jan;27(1):133-9 PMID: 6244225
  36. Monoclonal antibodies to hemagglutinin and to H-2 inhibit the cross-reactive cytotoxic T cell populations induced by influenza.
    Eur J Immunol. 1980 Feb;10(2):151-56 PMID: 6966222
  37. Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection.
    J Exp Med. 1980 Apr 1;151(4):815-26 PMID: 6966309
  38. Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infectious cycle as determined by antibody-dependent cell-mediated cytotoxicity.
    Infect Immun. 1980 Apr;28(1):38-44 PMID: 6247286
  39. Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity.
    J Gen Virol. 1980 Jun;48(Pt 2):351-7 PMID: 6249885
  40. Cell-mediated immunity in herpes simplex virus-infected mice: suppression of delayed hypersensitivity by an antigen-specific B lymphocyte.
    J Gen Virol. 1980 Jun;48(Pt 2):359-64 PMID: 6249886
  41. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice.
    Eur J Immunol. 1980 May;10(5):396-401 PMID: 6967815
  42. MHC matching shows that at least two T-cell subsets determine resistance to HSV.
    Nature. 1979 Jan 4;277(5691):66-8 PMID: 233263
  43. Cell-mediated immunity in herpes simplex virus-infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells.
    J Gen Virol. 1980 Aug;49(2):309-17 PMID: 6255070
  44. Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2.
    J Virol. 1980 Aug;35(2):428-35 PMID: 6255183
  45. The nature of host-cell herpes-simplex virus interactions(s) that renders cells susceptible to virus-specific cytotoxic T cells.
    Immunobiology. 1980 Dec;157(4-5):365-78 PMID: 6256287
  46. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
    J Immunol. 1981 Jan;126(1):304-8 PMID: 6969745
  47. gA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide.
    J Virol. 1980 Dec;36(3):665-75 PMID: 6162034
  48. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
    J Immunol. 1981 Apr;126(4):1260-2 PMID: 6259256
  49. Influenza type A virus M protein expression on infected cells is responsible for cross-reactive recognition by cytotoxic thymus-derived lymphocytes.
    Infect Immun. 1980 Aug;29(2):719-23 PMID: 7011983
  50. The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity.
    J Immunol. 1981 May;126(5):1655-60 PMID: 6971309
  51. Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity.
    Immunology. 1981 May;43(1):153-9 PMID: 7251047
  52. Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity.
    Immunology. 1981 Jun;43(2):363-9 PMID: 6265348
  53. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.
    Proc Natl Acad Sci U S A. 1981 Aug;78(8):5202-6 PMID: 6272294
  54. The isolation and properties of a variant of Herpes simplex producing multinucleated giant cells in monolayer cultures in the presence of antibody.
    Am J Hyg. 1959 Sep;70:208-19 PMID: 14402487
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1982-07-00
Pages
116-26
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC347498
Subset
IM
Grants
NCI NIH HHS · CA 09124 · United States
NCI NIH HHS · CA 18450 · United States
NCI NIH HHS · CA 27503 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com